A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC

Autor: Noronha, Vanita, Menon, Nandini S., Patil, Vijay Maruti, Chandrakanth, M.V., More, Sucheta, Dhanawat, Aditya, Chowdhary, Oindrila Roy, Singh, Ajaykumar Chandrabhan, Goud, Supriya, Shah, Srushti, Karuvandan, Naveen, Jobanputra, Kunal Naishadh, Shah, Darshit Kalpeshkumar, Shah, Minit Jalan, Sarma, Rupjyoti, Patel, Dhwaniben, Joarder, Ritam, Kumar, Prashant, John, Anupa, Kaur, Jaspreet, Bagra, Saurabh, Purandare, Nilendu, Janu, Amit, Mahajan, Abhishek, Prabhash, Kumar
Zdroj: In JTO Clinical and Research Reports January 2024 5(1)
Databáze: ScienceDirect